Content about Final

PLEASANTON, Calif. — Safeway on Tuesday said that it expects to earn $1.60 to $1.80 per diluted share during the quarter, after the company's board approved a $1.1 billion dividend from Canada to the United States.

The dividend, Safeway said during its 2011 investor conference, will be used to pay off $600 million of U.S. debt, and the company will use the remainder of the dividend for share repurchases.

LOS ANGELES — Freeman Beauty debuted its revamped website, which embraces the bright and bold attitude of its products, the company said.

The site, which premiered Monday, features easy-to-use navigation and allows consumers to buy Freeman Beauty products through its “Buy Now” one-click purchasing. What's more, the company said, the site offers free shipping on orders valued at more than $35 and includes free samples with all orders.

LEHIGH VALLEY, Pa. — HealthOneMed has launched a device that combines the abilities of pillboxes, reminders, dispensers and medication alerts into one.

GREENSBORO, N.C. — Merz Pharmaceuticals has created two programs to provide financial assistance to patients using its drug for cervical dystonia, the company said Tuesday.

The programs — the Xeomin patient co-payment program and the Xeomin patient assistance program — cover Xeomin (incobotulinumtoxinA), designed to decrease the severity of abnormal head positions and neck pains in patients with the disease, which causes muscle contractions resulting in repetitive movements and abnormal postures.

PRINCETON, N.J. — The Food and Drug Administration has accepted a regulatory approval application for a Type 2 diabetes drug from Bristol-Myers Squibb and AstraZeneca, the two drug makers said Tuesday.

The FDA accepted the application for dapagliflozin, an investigational drug for adults with the disease. The Centers for Disease Control and Prevention estimated that 1-in-11 U.S. adults has diabetes, with 90% to 95% of them having Type 2 diabetes.

The agency expects to take action on the application in late October.

CHICAGO — An ultra-concentrated, multisurface cleaner in a reusable bottle system is being rolled out at select Whole Foods stores.

Replenish said its all-in-one bottle will be available next month in 33 of Whole Foods' stores in the Midwest. The system, the company said, allows consumers to measure, mix with water, store and spray powerful cleaners using replaceable concentrate pods, instead of buying premixed cleaners.

Replenish is available in three scents: fresh lavender, sun lemon and green tea.

TOKYO — Two years after launching a nonalcoholic beer in its native Japan, Kirin Brewery said it was taking the hit beverage for a test run in the United States.

The company reportedly will bring Kirin Free, a beverage that touts 0.00% alcohol, to select retailers in California, according to the Wall Street Journal.

Kirin currently sells its Kirin Ichiban and Kirin Light beers in the United States.

MASHPEE, Mass. — Amid reports of a nationwide bed bug outbreak, a new pesticide-free solution has hit the market.

Stop Bugging Me!, a natural bed bug treatment designed for at-home and commercial use, can be sprayed directly onto any detergent-safe upholstery, including bedding, linens and clothing, killing bed bugs and their eggs. Stop Bugging Me! includes such natural, active ingredients as 2-phenethyl propionate (a natural insecticide), eugenol, sodium lauryl sulfate, geraniol and cinnamon oil with aromatic bark.

ST. PAUL, Minn. — UltiMed is offering 50-count pen needles for patients with diabetes, the company announced.

The company said the needles would give diabetes patients a high-quality and cost-effective option for their pen needle supplies. Before, pen needles were dispensed in quantities of 100.

UltiMed said its needles, manufactured in its De Smet, S.D., factory, are the only ones assembled in the United States.

MORRISTOWN, N.J. — Actavis last week named Lisa Buono to lead its over-the-counter drug division as part of the company’s strategic expansion of the division.

As director of OTC, Buono will oversee the division’s day-to-day operations and will focus on identifying and capitalizing on new product opportunities. Actavis manufactures and distributes numerous nonprescription liquids, creams and ointments sold under the Actavis label and its customers’ own brands, as well as FeverAll brand acetaminophen suppositories.

SHANGHAI — Drug maker Bristol-Myers Squibb is opening a new testing facility in China under collaboration with a local company there, Bristol said Monday.

WuXi PharmaTech will build, equip and operate the 25,000-sq.-ft. lab in Shanghai to store and test stability samples and perform other services for Bristol.